You guys gotta be careful with those gap downs. Especially when it comes to pharma FDA failures. You typically don't get the same kind of bounce as you would with a stock that legitimately dropped down over multiple candles. What tends to happen is the price lingers near where it opened, then proceeds to dip, forming a new opportunity later to bounce near the point of the original gap down.
Market Data 
Markets 
AI
